STOCK TITAN

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has announced its participation in two upcoming healthcare conferences in September 2024. The company will be present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 at 9:15 a.m. ET in New York City, and the Wells Fargo 2024 Healthcare Conference on September 5 at 3:45 p.m. ET in Boston.

RxSight specializes in providing high-quality customized vision to patients following cataract surgery. Both conference appearances will feature fireside chats with company representatives. Interested parties can access live and archived webcasts of these events through the company's investor relations website at https://investors.rxsight.com/.

RxSight, Inc. (NASDAQ: RXST), una società di dispositivi medici oftalmici, ha annunciato la sua partecipazione a due imminenti conferenze sanitarie a settembre 2024. L'azienda sarà presente alla 22ª Conferenza Sanitaria Globale Annuale di Morgan Stanley il 4 settembre alle 9:15 a.m. ET a New York, e alla Conferenza Sanitaria 2024 di Wells Fargo il 5 settembre alle 3:45 p.m. ET a Boston.

RxSight si specializza nell'offrire visione personalizzata di alta qualità ai pazienti dopo l'intervento di cataratta. Entrambe le apparizioni alle conferenze includeranno conversazioni informali con i rappresentanti dell'azienda. Le parti interessate possono accedere a webcast in diretta e archiviati di questi eventi tramite il sito web delle relazioni con gli investitori dell'azienda su https://investors.rxsight.com/.

RxSight, Inc. (NASDAQ: RXST), una empresa de dispositivos médicos oftálmicos, ha anunciado su participación en dos conferencias de salud próximas en septiembre de 2024. La empresa estará presente en la 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre a las 9:15 a.m. ET en Nueva York, y en la Conferencia de Salud 2024 de Wells Fargo el 5 de septiembre a las 3:45 p.m. ET en Boston.

RxSight se especializa en proporcionar visión personalizada de alta calidad a pacientes tras la cirugía de cataratas. Ambas apariciones en las conferencias incluirán charlas informales con representantes de la empresa. Las partes interesadas pueden acceder a transmisiones en vivo y grabadas de estos eventos a través del sitio web de relaciones con inversores de la empresa en https://investors.rxsight.com/.

RxSight, Inc. (NASDAQ: RXST), 안과 의료기기 회사가 2024년 9월에 개최되는 두 개의 건강 회의에 참여한다고 발표했습니다. 이 회사는 9월 4일 오전 9시 15분 ET에 뉴욕시에서 열리는 모건 스탠리 제22회 연례 글로벌 헬스케어 회의와 9월 5일 오후 3시 45분 ET에 보스턴에서 열리는 웰스 파고 2024 헬스케어 회의에 참석할 예정입니다.

RxSight는 백내장 수술 후 환자에게 맞춤형 고품질 시력을 제공하는 전문 회사입니다. 두 회의에서는 회사 대표와의 편안한 대화가 포함될 것입니다. 관심 있는 분들은 회사의 투자자 관계 웹사이트 https://investors.rxsight.com/를 통해 이 행사들의 실시간 및 기록된 웹캐스트를 이용할 수 있습니다.

RxSight, Inc. (NASDAQ: RXST), une entreprise spécialisée dans les dispositifs médicaux ophtalmiques, a annoncé sa participation à deux conférences de santé à venir en septembre 2024. L'entreprise sera présente à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 4 septembre à 9h15 ET à New York, et à la Conférence de Santé 2024 de Wells Fargo le 5 septembre à 15h45 ET à Boston.

RxSight se spécialise dans la fourniture d'une vision personnalisée de haute qualité aux patients après une chirurgie de la cataracte. Les deux apparitions lors des conférences comprendront des discussions informelles avec des représentants de l'entreprise. Les personnes intéressées peuvent accéder aux webcasts en direct et archivés de ces événements via le site web des relations avec les investisseurs de l'entreprise à l'adresse suivante : https://investors.rxsight.com/.

RxSight, Inc. (NASDAQ: RXST), ein Unternehmen für ophthalmologische Medizinprodukte, hat seine Teilnahme an zwei bevorstehenden Gesundheitskonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird am 4. September um 9:15 Uhr ET in New York City auf der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley und am 5. September um 15:45 Uhr ET in Boston auf der Wells Fargo 2024 Gesundheitskonferenz vertreten sein.

RxSight ist spezialisiert auf die Bereitstellung hochwertiger, maßgeschneiderter Sehlösungen für Patienten nach einer Kataraktoperation. Beide Konferenzauftritte werden informelle Gespräche mit Unternehmensvertretern beinhalten. Interessierte können über die Investor-Relations-Website des Unternehmens unter https://investors.rxsight.com/ auf die Live- und aufgezeichneten Webcasts dieser Veranstaltungen zugreifen.

Positive
  • None.
Negative
  • None.

ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September.

  • Morgan Stanley 22nd Annual Global Healthcare Conference
    - Fireside Chat: Wednesday, September 4, 2024, at 9:15 a.m. ET in New York City, NY
  • Wells Fargo 2024 Healthcare Conference
    - Fireside Chat: Thursday, September 5, 2024, at 3:45 p.m. ET in Boston, MA

Interested parties may access live and archived webcasts of these events at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+™, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com


FAQ

When and where will RxSight (RXST) participate in the Morgan Stanley healthcare conference?

RxSight (RXST) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, at 9:15 a.m. ET in New York City, NY.

What is the date and time for RxSight's (RXST) fireside chat at the Wells Fargo healthcare conference?

RxSight's (RXST) fireside chat at the Wells Fargo 2024 Healthcare Conference is scheduled for Thursday, September 5, 2024, at 3:45 p.m. ET in Boston, MA.

How can investors access the webcasts of RxSight's (RXST) conference appearances?

Investors can access live and archived webcasts of RxSight's (RXST) conference appearances at https://investors.rxsight.com/.

What type of medical devices does RxSight (RXST) specialize in?

RxSight (RXST) specializes in ophthalmic medical devices that provide high-quality customized vision to patients following cataract surgery.

RxSight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Stock Data

2.18B
39.68M
5.15%
88.99%
6.91%
Medical Devices
Ophthalmic Goods
Link
United States of America
ALISO VIEJO